The pathogenesis of coronary artery disease and the acute coronary syndromes (2).
暂无分享,去创建一个
[1] J J Albers,et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.
[2] F. Feit,et al. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. , 1989, Circulation.
[3] D. Massel,et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.
[4] Steven E. Nissen,et al. Intravascular Ultrasound Assessment of Lumen Size and Wall Morphology in Normal Subjects and Patients With Coronary Artery Disease , 1991, Circulation.
[5] M. Lewis,et al. Endothelium‐derived relaxing factor inhibits in vitro platelet aggregation , 1987, British journal of pharmacology.
[6] R. Califf,et al. Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, Journal of the American College of Cardiology.
[7] F. Crea,et al. Abnormal Vasomotor Changes Early After Coronary Angioplasty: A Quantitative Arteriographic Study of Their Time Course , 1991, Circulation.
[8] S. Chierchia,et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.
[9] J. Thyberg,et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.
[10] J. Steinberg. Book ReviewAmbulatory Pediatric Care , 1989 .
[11] M. J. Mitchinson,et al. MACROPHAGES AND ATHEROGENESIS , 1987, The Lancet.
[12] M. Winniford,et al. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. , 1986, Journal of the American College of Cardiology.
[13] H. Waldmann,et al. Monocytic origin of foam cells in human atherosclerotic plaques. , 1984, Atherosclerosis.
[14] V. Fuster,et al. The Role of Collateral Circulation in the Various Coronary Syndromes , 1979, Circulation.
[15] F. Bühler,et al. Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension. , 1988, American heart journal.
[16] Louis E. Teichholz,et al. Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .
[17] E. B. Smith,et al. Fate of fibrinogen in human arterial intima. , 1990, Arteriosclerosis.
[18] J. Badimón,et al. Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. , 1989, The Journal of clinical investigation.
[19] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[20] C. Benedict,et al. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. , 1989, Circulation.
[21] D. Ku,et al. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.
[22] J. Stamler,et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.
[23] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[24] A. Gown,et al. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.
[25] A. Hassett,et al. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. , 1989, The Journal of laboratory and clinical medicine.
[26] N. Miller,et al. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. , 1989, Arteriosclerosis.
[27] D. Steinberg,et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Maseri,et al. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.
[29] J. Ordovás,et al. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[30] G. V. R. Born,et al. INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.
[31] R Gorlin,et al. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. , 1989, Journal of the American College of Cardiology.
[32] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[33] V. Fuster,et al. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.
[34] V. Fuster,et al. Angiographic evolution of coronary artery morphology in unstable angina. , 1986, Journal of the American College of Cardiology.
[35] L. Wilhelmsen,et al. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.
[36] W. Daniel,et al. Increased Thrombin Levels During Thrombolytic Therapy in Acute Myocardial Infarction: Relevance for the Success of Therapy , 1991, Circulation.
[37] E. Falk. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. , 1989, The American journal of cardiology.
[38] P. Rentrop,et al. Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris , 1981, Circulation.
[39] W. Little,et al. Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction. , 1990, The American journal of cardiology.
[40] V. Fuster,et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.
[41] A. Yeung,et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.
[42] H V Anderson,et al. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Reidy,et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.
[44] R. Cotran,et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.
[45] N. Simionescu,et al. Prelesional Modifications of the Vessel Wall in Hyperlipidemic Atherogenesis , 1990, Annals of the New York Academy of Sciences.
[46] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[47] V. Fuster,et al. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. , 1987, Circulation.
[48] R. Bar-Shavit,et al. Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. , 1989, The Journal of clinical investigation.
[49] M. Yanagisawa,et al. INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION , 1989, The Lancet.
[50] F. Zak,et al. Morphodynamic Interpretation of Acute Coronary Thrombosis, with Special Reference to Volcano-Like Eruption of Atheromatous Plaque Caused by Coronary Artery Spasm , 1988, Angiology.
[51] M. Reidy,et al. Role of basic fibroblast growth factor in vascular lesion formation. , 1991, Circulation research.
[52] R. Friedman,et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. , 1977, The Journal of clinical investigation.
[53] V. Fuster,et al. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. , 1988, Journal of the American College of Cardiology.
[54] J. Vane,et al. Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.
[55] G. Dahlén,et al. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. , 1989, European heart journal.
[56] R D Fish,et al. Loss of Flow‐Mediated Endothelium‐Dependent Dilation Occurs Early in the Development of Atherosclerosis , 1991, Circulation.
[57] L. Wilhelmsen,et al. Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.
[58] G. Bondjers,et al. Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.
[59] V. Fuster,et al. An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall , 1990 .
[60] M. Territo,et al. Monocyte Chemotactic Factor Produced by Large Vessel Endothelial Cells in Vitro , 1986, Arteriosclerosis.
[61] L. V. von Segesser,et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? , 1990, Circulation.
[62] J. Vane,et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.
[63] J. Cullen,et al. International control of smoking and the US experience. , 1986, Chest.
[64] H. Drexler,et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.
[65] D. Hathaway,et al. Molecular cardiology: new avenues for the diagnosis and treatment of cardiovascular disease. , 1989, Journal of the American College of Cardiology.
[66] T. Drake,et al. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. , 1989, The American journal of pathology.
[67] B. G. Brown,et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. , 1991, Circulation.
[68] S. Chierchia,et al. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. , 1987, The New England journal of medicine.
[69] W. Roberts,et al. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. , 1972, The American journal of medicine.
[70] J. Breslow,et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.
[71] M. Nobuyoshi,et al. Progression of coronary atherosclerosis: is coronary spasm related to progression? , 1991, Journal of the American College of Cardiology.
[72] S. Willich,et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. , 1987, The New England journal of medicine.
[73] C. Francis,et al. Thrombin activity of fibrin thrombi and soluble plasmic derivatives. , 1983, The Journal of laboratory and clinical medicine.
[74] W. F. Fulton,et al. The coronary arteries : Arteriography, microanatomy, and pathogenesis of obliterative coronary artery disease , 1965 .
[75] E. Braunwald,et al. Unstable angina. A classification. , 1989, Circulation.
[76] A. J. Valente,et al. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. , 1988, Biochemistry.
[77] S. Thompson,et al. HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.
[78] A. Angelini,et al. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. , 1989, European heart journal.
[79] S. Davies,et al. Irregular coronary lesion morphology after thrombolysis predicts early clinical instability. , 1991, Journal of the American College of Cardiology.
[80] H. Goldsmith,et al. Flow Patterns in Vessels of Simple and Complex Geometries a , 1987, Annals of the New York Academy of Sciences.
[81] J. Loscalzo,et al. Lipoprotein(a). A unique risk factor for atherothrombotic disease. , 1990, Arteriosclerosis.
[82] O. Paul. Background of the Prevention of Cardiovascular Disease: II. Arteriosclerosis, Hypertension, and Selected Risk Factors , 1989, Circulation.
[83] V. Fuster,et al. Arteriosclerosis in Normal and von Willebrand Pigs: Long‐Term Prospective Study and Aortic Transplantation Study , 1982, Circulation research.
[84] G. FitzGerald,et al. Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[85] F. España,et al. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. , 1988, British heart journal.
[86] R. Califf,et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.
[87] L. Hillis,et al. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.
[88] White Hd. GISSI-2 and the heparin controversy. , 1990 .
[89] L Morgenstern,et al. Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.
[90] R Gorlin,et al. Angiographic demonstration of a common link between unstable angina pectoris and non-Q-wave acute myocardial infarction. , 1988, The American journal of cardiology.
[91] W. Roberts,et al. Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. , 1991, Journal of the American College of Cardiology.
[92] J P Matts,et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.
[93] J Pekkanen,et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.
[94] G. Boers,et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.
[95] K. Griendling,et al. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. , 1990, The Journal of biological chemistry.
[96] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[97] K. Pritchard,et al. Native low density lipoprotein. Endothelial cell recruitment of mononuclear cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[98] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[99] P. Libby,et al. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.
[100] A. Barger,et al. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. , 1990, The American journal of cardiology.
[101] P. Constantinides,et al. Plaque fissures in human coronary thrombosis , 1966 .
[102] V. Fuster,et al. Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid artery , 1990 .
[103] P. Cohen,et al. Platelets and atherogenesis , 1968 .
[104] M. Reidy,et al. Regulation of Smooth Muscle Cell Growth in Injured Artery , 1989, Journal of cardiovascular pharmacology.
[105] J L Witztum,et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.
[106] R M Nerem,et al. The pathogenesis of atherosclerosis: An overview , 1991, Clinical cardiology.
[107] G. Hutchins,et al. The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis. , 1977, American heart journal.
[108] S. Willich,et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. , 1989, Circulation.
[109] V. Fuster,et al. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. , 1985, Circulation research.
[110] V. Fuster,et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.
[111] D. Steinberg. Antioxidants and atherosclerosis. A current assessment. , 1991, Circulation.
[112] D. Gordon,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.
[113] M. Yanagisawa,et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. , 1991, Circulation.
[114] J. Eidt,et al. Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.
[115] V. Fuster,et al. Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. , 1978, The Journal of clinical investigation.
[116] D C Levin,et al. Significance of the Angiographic Morphology of Localized Coronary Stenoses: Histopathologic Correlations , 1982, Circulation.
[117] W. Santamore,et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.
[118] S. Vallabhajosula,et al. Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth. , 1990, Arteriosclerosis.
[119] M. Reidy,et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[120] K. Zitnay,et al. Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.
[121] R. D'Agostino,et al. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.
[122] J. Newhouse,et al. Are We Training Too Many Subspecialists?-Reply , 1988 .
[123] K. Gould,et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.
[124] R. W. Brower,et al. Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trial. , 1987, European heart journal.
[125] G. FitzGerald,et al. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. , 1988, Circulation.
[126] R. Detrano,et al. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. , 1989, American heart journal.
[127] M. Winniford,et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. , 1986, Circulation.
[128] V. Fuster,et al. Insights into the pathogenesis of acute ischemic syndromes. , 1988, Circulation.
[129] L. Wilhelmsen,et al. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. , 1990, BMJ.
[130] V. Fuster,et al. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[131] B. Hunt. The relation between abnormal hemostatic function and the progression of coronary disease , 1990 .
[132] R. Mesa-Tejada,et al. Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies , 1989, Arteriosclerosis.
[133] T. P. Judge,et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. , 1986, The New England journal of medicine.
[134] V. Fuster,et al. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[135] H. Shimokawa,et al. Endothelium‐Derived Relaxing Factor and Coronary Vasospasm , 1989, Circulation.
[136] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[137] R. Kerber,et al. Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. , 1987, The New England journal of medicine.
[138] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[139] F. Van de Werf,et al. Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis. , 1990, Journal of the American College of Cardiology.
[140] A. Gotto,et al. CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .
[141] A. Jaffe,et al. Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. , 1987, Journal of the American College of Cardiology.
[142] M. Bourassa,et al. Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients. , 1984, The American journal of cardiology.
[143] E L Bolson,et al. Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. , 1986, Circulation.
[144] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[145] M. Yacoub,et al. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.
[146] A. Maseri,et al. Coronary constriction in acute myocardial infarction: role of nitrates. , 1988, European heart journal.
[147] L. Guize,et al. Factor VII activation and menopausal status. , 1990, Thrombosis research.
[148] E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.
[149] M. Blombäck,et al. PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.
[150] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[151] S. Davies,et al. Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. , 1990, Journal of the American College of Cardiology.
[152] D. McGill,et al. The relationship between blood fibrinogen level and coronary artery disease , 1990 .
[153] M. Friedman,et al. The pathogenesis of a coronary thrombus. , 1966, The American journal of pathology.
[154] J. Pepper,et al. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. , 1988, British heart journal.
[155] R. Ross,et al. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. , 1976, The Journal of clinical investigation.
[156] B. Gordon,et al. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[157] E. Boerwinkle,et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.
[158] M. Brown,et al. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.
[159] V. Fuster,et al. Platelet Survival and the Development of Coronary Artery Disease in the Young Adult: Effects of Cigarette Smoking, Strong Family History and Medical Therapy , 1981, Circulation.
[160] Y. Yazaki,et al. Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells , 1988, FEBS letters.
[161] J. B. Duguid. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. , 1946, The Journal of pathology and bacteriology.
[162] Kathleen M. Smith,et al. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.
[163] P. Serruys,et al. Angina pectoris. What will be the requirements for acute interventional procedures in Europe? , 1987, European heart journal.
[164] H. Araki,et al. Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo. , 1990, Circulation research.
[165] N. Wolf,et al. Frequency of intracoronary filling defects by angiography in angina pectoris at rest. , 1985, The American journal of cardiology.
[166] E. Braunwald,et al. Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.
[167] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[168] J. Guyton,et al. Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core. , 1986, The American journal of pathology.
[169] L Roy,et al. Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.
[170] M. Stadius,et al. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. , 1988, Circulation.
[171] M. Freeman,et al. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.
[172] T. Wight,et al. Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.
[173] V. Fuster,et al. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. , 1988, Circulation.
[174] Kathleen M. Smith,et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[175] A. M. Lefer,et al. Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. , 1989, The Journal of clinical investigation.
[176] P. Ganz,et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. , 1990, Circulation.
[177] R. Collins,et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. , 1989, Circulation.
[178] L. Romics,et al. Lipoprotein (a) and plasminogen are immunochemically related. , 1988, Biochimica et biophysica acta.
[179] K. Friedman,et al. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. , 1988, Blood.